CalPERS approves 7.2% increase in HMO rates as drug costs climb

Jun 18, 2015

CalPERS said it spent nearly $40 million for Sovaldi on plans run by Blue Shield of California, Kaiser Permanente and CVS Health. Read More

Press Release: New Trend Report Confirms Drug Prices On Unsustainable Path

May 13, 2015

May 13, 2015 New Drug Report Reveals Drug Costs Top $50,000/year for Over Half Read More

[Kaiser Health News] Costly Hepatitis C Treatments Help Drive 12 Percent Drug Spending Jump

Nov 20, 2014

After several years of modest increases, American spending on medications is projected to shoot up by 12 percent this year, pushing the nation’s drug bill to between $375 billion and $385 billion, according to a report by the IMS Institute for Healthcare Informatics. Read More

[SF Business Times] Gilead’s $1,000-a-pill hepatitis C drug may make financial sense for prisons

Oct 20, 2014

Pricey new hepatitis C drugs, such as Gilead Sciences Inc.'s Sovaldi, may make financial sense to give to give to prisoners, one of the main groups infected with the liver-damaging virus, according to a team of Stanford University researchers. Read More